LGMN and acute lymphoblastic leukemia: We have shown that overexpression of AEP is seen in high risk cytogenetic subtypes of childhood acute lymphoblastic leukaemia (ALL) [14]; correlates with CNS infiltration in ALL [15] and that the enzyme cleaves and degrades a key anticancer drug used in the treatment of ALL [9].